Protagonist Therapeutics · 1 month ago
Patent Agent, Intellectual Property
Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company, seeking a Patent Agent to join their Intellectual Property practice. The successful candidate will be responsible for invention capture, patent drafting, prosecution, and assisting with IP-related agreements.
BiotechnologyHealth CareMedical
Responsibilities
Foster a collaborative culture interacting with our scientists to understand and monitor the development of key inventions
Investigate the relevant state of the art to assess the patentability and to devise a drafting strategy for inventions
Draft or co-draft key patent applications with outside counsel
Work with outside counsel for preparing patent filings and to manage active prosecution, both domestic and international
Assist on IP-related agreements, including confidentiality, joint research, and license agreements
Assist in maintaining databases and spreadsheets relating to the IP portfolio
Assist in trademark portfolio management
Qualification
Required
PhD in Medicinal Chemistry, Molecular Biology, Cell Biology, Genetics, or similar field, or an MS in organic chemistry with a strong background in molecular biology
Two to four years of experience working as a patent agent or scientific advisor (pre-patent bar registration) with a law firm and/or inhouse legal group
Candidates should either have already passed the patent bar (patent agent) or is willing to take and pass the patent bar after joining the company (scientific advisor)
Organized, calm, and positive approach under deadlines
Excellent communication skills, both oral and written. A writing sample will be requested
Independent, curious, and proactive learner – not afraid to dive-into and learn new technologies and to grow your expertise in patent law
Company
Protagonist Therapeutics
Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.
Funding
Current Stage
Public CompanyTotal Funding
$388.99MKey Investors
National Institutes of HealthCanaan PartnersPharmstandard
2021-06-14Post Ipo Equity· $132.2M
2020-12-10Post Ipo Equity· $115M
2019-10-31Post Ipo Debt· $50M
Recent News
2026-01-06
Pharmaceutical Technology
2026-01-06
Company data provided by crunchbase